Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 10;10(11):1723.
doi: 10.3390/nu10111723.

Therapeutic Microbiology: The Role of Bifidobacterium breve as Food Supplement for the Prevention/Treatment of Paediatric Diseases

Nicole Bozzi Cionci  1 , Loredana Baffoni  2 , Francesca Gaggìa  3 , Diana Di Gioia  4
Affiliations
Review

Therapeutic Microbiology: The Role of Bifidobacterium breve as Food Supplement for the Prevention/Treatment of Paediatric Diseases

Nicole Bozzi Cionci et al. Nutrients. .

Abstract

The human intestinal microbiota, establishing a symbiotic relationship with the host, plays a significant role for human health. It is also well known that a disease status is frequently characterized by a dysbiotic condition of the gut microbiota. A probiotic treatment can represent an alternative therapy for enteric disorders and human pathologies not apparently linked to the gastrointestinal tract. Among bifidobacteria, strains of the species Bifidobacterium breve are widely used in paediatrics. B. breve is the dominant species in the gut of breast-fed infants and it has also been isolated from human milk. It has antimicrobial activity against human pathogens, it does not possess transmissible antibiotic resistance traits, it is not cytotoxic and it has immuno-stimulating abilities. This review describes the applications of B. breve strains mainly for the prevention/treatment of paediatric pathologies. The target pathologies range from widespread gut diseases, including diarrhoea and infant colics, to celiac disease, obesity, allergic and neurological disorders. Moreover, B. breve strains are used for the prevention of side infections in preterm newborns and during antibiotic treatments or chemotherapy. With this documentation, we hope to increase knowledge on this species to boost the interest in the emerging discipline known as "therapeutic microbiology".

Keywords: Bifidobacterium breve; paediatrics; probiotics; therapeutic microbiology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Paediatric diseases in which an amelioration of symptoms has been obtained upon B. breve strains administration.
See this image and copyright information in PMC

References

    1. Spinler J.K., Versalovic J. Probiotics in Human Medicine: Overview. In: Versalovic J., Wilson M., editors. Therapeutic Microbiology: Probiotics and Related Strategies. 1st ed. ASM Press; Washington, DC, USA: 2008. pp. 225–229.
    1. Maassen C.B.M., Van Holten-Neelen C., Balk F., Heijne Den Bak-Glashouwer M.J., Leer R.J., Laman J.D., Boersma W.J.A., Claassen E. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine. 2000;18:2613–2623. doi: 10.1016/S0264-410X(99)00378-3. - DOI - PubMed
    1. O’Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7:688–693. doi: 10.1038/sj.embor.7400731. - DOI - PMC - PubMed
    1. Frank D.N., St. Amand A.L., Feldman R.A., Boedeker E.C., Harpaz N., Pace N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. USA. 2007;104:13780–13785. doi: 10.1073/pnas.0706625104. - DOI - PMC - PubMed
    1. Sánchez B., Delgado S., Blanco-Míguez A., Lourenço A., Gueimonde M., Margolles A. Probiotics, gut microbiota, and their influence on host health and disease. Mol. Nutr. Food Res. 2016;61:1600240. doi: 10.1002/mnfr.201600240. - DOI - PubMed

LinkOut - more resources